Rafael Holdings
NYSE: RFLNewark, US · Founded 2017 · Delaware corporation
Find your way into Rafael Holdings
Sign up to see every warm intro you have to Rafael Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rafael Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rafael Holdings is a publicly traded (NYSE: RFL) company focused on the discovery and development of oncology therapeutics through a wholly-owned portfolio of companies, with multiple clinical programs including two Phase 3 trials. It is transitioning from a clinical-stage company toward a commercial pharmaceutical enterprise.
Founders & leadership
Rafael Holdings was founded in 2017 by Howard S. Jonas.

Board
Reported raises · per SEC filings
Form D private placements$104.2M disclosed across 1 round · 2021
▶$104.2MraisedAug 2021 · 17 investors · BiotechnologyRule 506(b)
- Michael J. WeissDirector
- David A. PolinskyExecutive Officer
- Shannon Thyme KlingerDirector
- Rachel JonasDirector
- Menachem AshExecutive Officer
- Mark McCamishDirector
- Boris C. PascheDirector
- Ameet MallikExecutive Officer, Director
- Stephen GreenbergDirector
- Howard S. JonasDirector
- Offering amount
- $104.2M
- Amount sold
- $104.2M
- Sales commissions
- $6M
- Placement agents
- SVB Leerink LLC, Raymond James & Associates, Inc.
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 10
Companies working in the same space as Rafael Holdings.
Frequently asked questions
- What does Rafael Holdings do?
- Rafael Holdings is a publicly traded (NYSE: RFL) company focused on the discovery and development of oncology therapeutics through a wholly-owned portfolio of companies, with multiple clinical programs including two Phase 3 trials. It is transitioning from a clinical-stage company toward a commercial pharmaceutical enterprise.
- Who founded Rafael Holdings?
- Rafael Holdings was founded by Howard S. Jonas in 2017.
- How much funding has Rafael Holdings raised?
- Rafael Holdings has disclosed $104.2M raised across 1 round.
- Where is Rafael Holdings headquartered?
- Rafael Holdings is headquartered in Newark, US.




